relatlimab,nivolumab
bms
['neopredict', 'nivolumab', 'nivo']
dr. clemens aigner discusses neopredict: neoadjuvant nivolumab +/- relatamab (lag3). pcr 13% and 17%. surgery certainly feasible after therapy but suggests important role of chemotherapy. #asco23 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo